Atypical cutaneous findings in a patient with systemic lupus erythematosus

Lupus

Volumn 12, Issue 5, 2003, Pages 413-417

  Elkayam, O ^a   Gat, A ^a   Lidgi, M ^b   Segal, R ^b   Yaron, M ^a   Caspi, D ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b Tel Aviv University Sackler Faculty of Medicine   (Israel)

Author keywords

Cutaneous; Miliary; Systemic lupus erythematosus; Tuberculosis

Indexed keywords

CORTICOSTEROID; METHOTREXATE; PREDNISONE; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; COMORBIDITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MILIARY TUBERCULOSIS; PRIORITY JOURNAL; SKIN BIOPSY; SKIN ULCER; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SKIN; TUBERCULOSIS, CUTANEOUS; TUBERCULOSIS, MILIARY;

EID: 0038579709     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203303lu376cr     Document Type: Article

References (20)

1. Sahn SA, Neff TA. Miliary tuberculosis. Am J Med 1974; 56: 495-505.
2. Yates VM, Ormerod LP. Cutaneous tuberculosis in Blackburn district (UK): a 15 year prospective series, 1981-95. Br J Dermatol 1997; 136: 483-489.
3. Sharma SK, Mohan A, Pande JN, Prasad KL, Gupta AK, Khilnani GC. Clinical profile, laboratory characteristics and outcome in miliary TB. Q J Med 1995; 88: 29-37.
4. Munt PW. Miliary tuberculosis in the chemotherapy era: with a clinical review in 69 American adults. Medicine (Baltimore) 1972; 51: 139-155.
5. Daikos GL, Uttamchandani RB, Tuda C, Fischl MA, Miller N, Cleary T, Saldana MJ. Disseminated miliary tuberculosis of the skin in patients with AIDS: report of four cases. Clin Infect Dis 1998; 27: 205-208.
6. Brown FS, Anderson RH, Bumett JW. Cutaneous tuberculosis. Am Acad Dermatol 1982; 6: 101-106.
7. Libraty DH, Byrd TF Cutaneous miliary tuberculosis in the AIDS era: case report and review. Clin Infect Dis 1996; 23: 706-710.
8. Chin PW, Kon CK, Wong KT. Cutaneous tuberculosis mimicking cellulitis in an immunosuppressed patient. Singapore Med J 1999; 40: 44-45.
9. Victorio-Navarra ST, Dy EE, Arroyo CG, Torralba TP. Tuberculosis among Fillipino patients with systemic lupus erythematosus. Semin Arthritis Rheum 1996; 26: 628-634.
10. Duzgun N, Duman M, Sonel B, Peksari Y, Erderm C, Tokgoz G. Lupus vulgaris in a patients with systemic lupus erythematosus and persistent IgG deficiency. Rheumatol Int 1997; 16: 213-216.
11. Edwards D, Kirkpatrick CH. The immunology of mycobacterial diseases. Am Rev Respir Dis 1986; 134: 1062-1071.
12. Dannenberg AMJ. Immune mechanisms in the pathogenesis of pulmonary tuberculosis. Rev Infect Dis 1989; 11: S369-378.
13. Dannenberg AMJ. Controlling tuberculosis. The pathologist's point of view. Res Microbiol 1990; 141: 192-263.
14. Sifford M, Bates JH. Host determinants of susceptibility to Mycobacterium tuberculosis. Semin Respir Infect 1991; 6: 44-55.
15. Piessens WF. Introduction to the immunology of tuberculosis. Rev Infect Dis 1989; 11: S436-442.
16. Kim HY, Im JG, Goo JM, Lee JK, Song JW, Kim SK. Pulmonary tuberculosis in patients with systemic lupus erythemaosus. Am J Rheumatol 1999; 173: 1639-1642.
17. Kim HA, Yoo CK, Baek HJ et al. Mycobacterium tuberculosis infection in a corticosteroid treated rheumatic disease patient population. Clin Exp Rheumatol 1998; 16: 9-13.
18. Masutani K, Akahoshi M, Tsuruya K et al. Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum 2001; 44(9): 2097-2106.
19. Gaitonde S, Pathan E, Sule A, Mittal G, Joshi VR. Efficacy of isoniazid prophylaxis in patients receiving long term steroid treatment. Ann Rheum Dis 2002; 61: 191-192.
20. Iseman MD. Tuberculosis therapy: past, present and future. Eur Respir J Suppl 2002; 36: 87s-94s.